IP Library Granted Patent US 9,636,315
Granted Patent B2
US 9,636,315 · App. 14/626,739 · Granted May 2, 2017

Compositions and methods for the sustained release of beta-alanine

Inventors: Roger Harris (New Market, GB); John Wise (San Marcos, CA)
Assignee: Natural Alternatives International, Inc.
A61K31/197A23L33/175A61K9/0095A61K9/06A61K9/48A61K9/4858A61K9/5015A61K31/445A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,315
App. No.
14/626,739
Granted
May 2, 2017
Kind
B2
Abstract

Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free beta-alanine. Also provided is a dietary supplement formulated, for example, as a solid food product, an edible suspension, liquid or semi-liquid as described herein.

Claims (11)

1. A human dietary supplement comprising free beta-alanine or a salt of free beta-alanine,

wherein the free beta-alanine or the salt of free beta-alanine in the human dietary supplement is a microencapsulated, sustained release formulation; wherein the human dietary supplement is a food product; wherein the human dietary supplement decreases the effects of paraesthesia, and delivers an effective amount of between about 0.1 g and about 10.0 g of the free beta-alanine or the salt of free beta-alanine to increase tissue anaerobic working capacity when provided over a prolonged period of time.

2. The human dietary supplement of claim 1 , wherein the food product is a solid food product.

3. The human dietary supplement of claim 2 , wherein the solid food product is selected from the group consisting of cookies, biscuits, chewing gum, lozenges, muffins, pies, tarts, cakes, and cereal flakes.

4. The human dietary supplement of claim 1 , wherein the food product is an edible suspension.

5. The human dietary supplement of claim 4 , wherein the edible suspension is selected from the group consisting of soup, yogurt, dairy or cheese spreads, margarines, meat and fish pastes, spreads and ice-cream.

6. The human dietary supplement of claim 1 , further comprising one or more additional components selected from the group consisting of vitamins, lipids, carbohydrates, amino acids, trace elements, colorings, flavors, artificial sweeteners, natural health improving substances, antioxidants, stabilizers, preservatives and buffers.

7. The human dietary supplement of claim 1 , further comprising creatine.

8. The human dietary supplement of claim 1 , further comprising one or more additional amino acids.

9. The human dietary supplement of claim 8 , wherein the one or more additional amino acids are selected from the group consisting of: L-cysteine and L-citrulline, and combinations thereof.

10. The human dietary supplement of claim 1 , further comprising one or more acetylcholine precursors selected from the group consisting of: choline chloride and phosphatidylcholine, and combinations thereof.

Assignments (2)
SECURITY INTEREST Recorded May 18, 2026
From: NATURAL ALTERNATIVES INTERNATIONAL, INC.
To: LEGACY CORPORATE LENDING, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 074684/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: HARRIS, ROGER; WISE, JOHN
To: NATURAL ALTERNATIVES INTERNATIONAL, INC.
Reel/Frame 035073/0519 →
Continuity (6)
Continuation 13929251 · Jun 27, 2013
Continuation 13755954 · Jan 31, 2013
Continuation 13646184 · Oct 5, 2012
Division 12064005
Provisional Application 60683985 · May 23, 2005
Related Publication 20150157587A1 · Jun 11, 2015